| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Oct 4, 2025 | Oct 7, 2025 | VOLITIONRX LTD | Chief Scientific Officer | Sell | 47.5 | -5,850 | -1.19% | ✗ | $3.8K |
| Sep 28, 2025 | Sep 30, 2025 | VOLITIONRX LTD | Chief Scientific Officer | Sell | 47.5 | -5,568 | -1.12% | ✗ | $3.4K |
| Jun 1, 2025 | Jun 3, 2025 | VOLITIONRX LTD | Chief Scientific Officer | Sell | 46.3 | -21,526 | -4.15% | ✗ | $10.8K |
| May 19, 2025 | May 19, 2025 | VOLITIONRX LTD | Chief Scientific Officer | Buy | 91.3 | +50,000 | 10.66% | ✗ | $21.5K |
| May 1, 2025 | May 5, 2025 | VOLITIONRX LTD | Chief Scientific Officer | Sell | 47.5 | -18,319 | -3.76% | ✗ | $8.9K |
| Dec 9, 2024 | Dec 10, 2024 | VOLITIONRX LTD | Chief Scientific Officer | Buy | 86.3 | +43,691 | 9.85% | ✗ | $25K |
| Oct 4, 2024 | Oct 8, 2024 | VOLITIONRX LTD | Chief Scientific Officer | Sell | 47.5 | -5,200 | -1.16% | ✗ | $4.6K |
| Sep 28, 2024 | Oct 1, 2024 | VOLITIONRX LTD | Chief Scientific Officer | Sell | 47.5 | -4,950 | -1.09% | ✗ | $2.9K |
| Aug 29, 2023 | Aug 31, 2023 | VOLITIONRX LTD | Chief Scientific Officer | Buy | 86.3 | +20,000 | 6.49% | ✗ | $25.1K |
| Aug 25, 2023 | Aug 28, 2023 | VOLITIONRX LTD | Chief Scientific Officer | Buy | 86.3 | +20,000 | 6.94% | ✗ | $24.8K |
| Aug 3, 2023 | Aug 7, 2023 | VOLITIONRX LTD | Chief Scientific Officer | Sell | 47.5 | -5,427 | -1.85% | ✗ | $7.1K |
| Dec 16, 2022 | Dec 20, 2022 | VOLITIONRX LTD | Chief Scientific Officer | Buy | 95.0 | +32,339 | 14.11% | ✗ | $71.9K |
| Sep 19, 2022 | Sep 20, 2022 | VOLITIONRX LTD | Chief Scientific Officer | Buy | 86.3 | +13,000 | 6.21% | ✗ | $22.1K |
| Aug 26, 2022 | Aug 30, 2022 | VOLITIONRX LTD | Chief Scientific Officer | Buy | 95.0 | +29,000 | 16.08% | ✗ | $50.5K |
| Aug 3, 2022 | Aug 5, 2022 | VOLITIONRX LTD | Chief Scientific Officer | Sell | 47.5 | -4,825 | -2.61% | ✗ | $9.5K |
| Aug 10, 2020 | Aug 12, 2020 | VOLITIONRX LTD | Chief Scientific Officer | Sell | 40.0 | -115,238 | -30.95% | ✗ | $403.3K |
| Nov 18, 2016 | Nov 21, 2016 | VOLITIONRX LTD | Chief Scientific Officer | Sell | 22.5 | -13,393 | -26.00% | ✗ | $60K |
| May 20, 2016 | May 24, 2016 | VOLITIONRX LTD | Chief Scientific Officer | Sell | 22.5 | -16,950 | -34.98% | ✗ | $60K |
| Dec 9, 2015 | Dec 18, 2015 | VOLITIONRX LTD | Chief Scientific Officer | Sell | 22.5 | -35,834 | -55.74% | ✗ | $150.5K |